| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 2 |
| 1 | CALCIUM | 2 |
| 2 | CYCLOPHOSPHAMIDE | 2 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 5 | FLUOROURACIL | 2 |
| 6 | FLUOROURACIL CREAM, 0.5% | 2 |
| 7 | GOSERELIN | 2 |
| 8 | LETROZOLE | 2 |
| 9 | LETROZOLE TABLETS | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 1 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 2 | GADOTERATE MEGLUMINE | 1 | 0.0003 |
| 3 | GOSERELIN | 2 | 0.0001 |
| 4 | RIBOCICLIB | 2 | 0.0001 |
| 5 | LETROZOLE TABLETS | 2 | 0.0000 |
| 6 | LETROZOLE | 2 | 0.0000 |
| 7 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 8 | FLUOROURACIL | 2 | 0.0000 |
| 9 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 1 | Calcium [EPC] | 2 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |